15:15 Dec 05

Bafna Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
143.15
-2.04 (-1.41%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bafna Pharmaceuticals Ltd. Financials

Bafna Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
143.15
-2.04 (-1.41%)
15:15 Dec 05
Quality
image/svg+xml

61/100
High Financial Strength

Valuation
image/svg+xml

54/100
Affordable Valuation

Technical

55/100
Technically Neutral

Strength

6

Weakness

6

Opportunity

0

Threats

0

-99.01 %

ROE %

-34.67 %

ROA %

3.71

EPS

-17.59

BVPS

-58.22 %

Net Profit Margin

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales
85.32 64.96 47.17 43.36 42.47
Operating Expenses +
84.8 70.77 82.31 56.7 41.24
Raw Material
66.73 55.01 34.19 26.99 23.22
Increase Decrease in Cost
-0.65 -3.09 4.09 0.81 -3.24
Other Manufacturing Expense
6.84 5.86 5.61 6.76 7.04
Employee Cost
6.99 6.81 7.47 9.01 10.25
Miscellaneous Expenses
106.67 86.58 56.93 14.05 4.01
Operating Profit
0.52 -5.81 -35.14 -13.34 1.23
Other Income
1.98 1.14 31.33 0.65 0.26
Depreciation
4.86 4.22 3.97 3.48 3.27
Interest
12.96 11.47 6.94 2.13 0.1
Profit before tax and exceptio..
-15.32 -20.36 -14.72 -18.29 -1.88
Exceptional Items
0 0 0 1.01 -22.56
PBT
-15.32 -20.36 -14.72 -17.28 -24.44
Provision for Taxation
-0.18 -0.9 2.19 1.07 0
Net Profit
-15.14 -19.46 -16.91 -18.35 -24.44
NET Profit after MI
-14.03 -19.09 -16.74 -18.87 -24.73
EPS
-8.8 -10.43 -7.15 -11.48 -15.52
Operating Profit Margin (%)
0.61 -8.94 -74.5 -30.77 2.9
Net Profit Margin (%)
-16.44 -29.39 -35.49 -43.52 -58.23

Bafna Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: